Jump to main content
Jump to site search

Issue 101, 2015
Previous Article Next Article

4-Aminoquinoline-hybridization en route towards the development of rationally designed antimalarial agents

Author affiliations

Abstract

The resistance of Plasmodium falciparum, the causative agent of malaria, against quinine and chloroquine along with the lack of malaria vaccines has encouraged the development of various synthetic strategies towards biologically active scaffolds. An emerging strategy in medicinal chemistry, termed molecular hybridization, involves the covalent fusion of two or more drugs, active compounds, and/or pharmacophoric units into a hybrid compound, with fascinating activities and multiple but not essentially simultaneous pharmacological targets. 4-Aminoquinolines are considered as promising antimalarials and 4-aminoquinoline hybridization is considered as an attractive and feasible approach for the development of new molecular frameworks for averting and delaying the emergence of drug resistance along with improved efficacy. The present review article describes the recent developments on the 4-aminoquinoline-hybridization towards the development of new antimalarials.

Graphical abstract: 4-Aminoquinoline-hybridization en route towards the development of rationally designed antimalarial agents

Back to tab navigation

Article information


Submitted
13 Aug 2015
Accepted
09 Sep 2015
First published
11 Sep 2015

RSC Adv., 2015,5, 82676-82698
Article type
Review Article
Author version available

4-Aminoquinoline-hybridization en route towards the development of rationally designed antimalarial agents

R. Raj, K. M. Land and V. Kumar, RSC Adv., 2015, 5, 82676
DOI: 10.1039/C5RA16361G

Social activity

Search articles by author

Spotlight

Advertisements